Theophylline Tablet, Extended Release
Product Images NDC 64380-243

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 64380-243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure-theophylline (7487d300 1a59 4410 84ae 8a36b24b15a9 01)

FDA Label Image

Label-300-mg (7487d300 1a59 4410 84ae 8a36b24b15a9 02)

FDA Label Image

Label-450-mg (7487d300 1a59 4410 84ae 8a36b24b15a9 03)

Label-450-mg (7487d300 1a59 4410 84ae 8a36b24b15a9 03)
The text provides information about an extended-release tablet containing 450mg of Theophylline, a medication used to treat respiratory diseases. It includes details on dosage, storage conditions, and manufacturer information. The tablet should be stored at 20° to 25°C and dispensed in a container with a child-resistant closure. The medication is distributed by Strides Pharma Inc. in East Brunswick, NJ.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.